These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 10497215)
1. Regulation of osteogenesis by fetuin. Binkert C; Demetriou M; Sukhu B; Szweras M; Tenenbaum HC; Dennis JW J Biol Chem; 1999 Oct; 274(40):28514-20. PubMed ID: 10497215 [TBL] [Abstract][Full Text] [Related]
2. Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist. Demetriou M; Binkert C; Sukhu B; Tenenbaum HC; Dennis JW J Biol Chem; 1996 May; 271(22):12755-61. PubMed ID: 8662721 [TBL] [Abstract][Full Text] [Related]
3. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells. Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602 [TBL] [Abstract][Full Text] [Related]
4. Regulation of human monocyte proMMP-9 production by fetuin, an endogenous TGF-beta antagonist. Tajirian T; Dennis JW; Swallow CJ J Cell Physiol; 2000 Nov; 185(2):174-83. PubMed ID: 11025439 [TBL] [Abstract][Full Text] [Related]
5. Effects of TGF-β1 on mineralization mediated by rat calvaria-derived osteogenic cells. Donato TA; Martinez EF; Arana-Chavez VE Microsc Res Tech; 2016 Dec; 79(12):1139-1146. PubMed ID: 27557631 [TBL] [Abstract][Full Text] [Related]
6. Progressive development of the osteoblast phenotype during differentiation of osteoprogenitor cells derived from fetal rat calvaria: model for in vitro bone formation. Yamamoto N; Furuya K; Hanada K Biol Pharm Bull; 2002 Apr; 25(4):509-15. PubMed ID: 11995934 [TBL] [Abstract][Full Text] [Related]
7. A modified rhTGF-beta1 and rhBMP-2 are effective in initiating a chondro-osseous differentiation pathway in bone marrow cells cultured in vitro. Andrades JA; Han B; Nimni ME; Ertl DC; Simpkins RJ; Arrabal MP; Becerra J Connect Tissue Res; 2003; 44(3-4):188-97. PubMed ID: 14504040 [TBL] [Abstract][Full Text] [Related]
8. Effects of transforming growth factor beta1 on bonelike tissue formation in three-dimensional cell culture. II: Osteoblastic differentiation. Lieb E; Vogel T; Milz S; Dauner M; Schulz MB Tissue Eng; 2004; 10(9-10):1414-25. PubMed ID: 15588401 [TBL] [Abstract][Full Text] [Related]
9. Effects of transforming growth factor beta1 on bonelike tissue formation in three-dimensional cell culture. I. Culture conditions and tissue formation. Lieb E; Milz S; Vogel T; Hacker M; Dauner M; Schulz MB Tissue Eng; 2004; 10(9-10):1399-413. PubMed ID: 15588400 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta 1 (TGF-beta1) prevents the age-dependent decrease in bone formation in human osteoblast/implant cultures. Zhang H; Aronow MS; Gronowicz GA J Biomed Mater Res A; 2005 Oct; 75(1):98-105. PubMed ID: 16044414 [TBL] [Abstract][Full Text] [Related]
11. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Rickard DJ; Sullivan TA; Shenker BJ; Leboy PS; Kazhdan I Dev Biol; 1994 Jan; 161(1):218-28. PubMed ID: 8293874 [TBL] [Abstract][Full Text] [Related]
12. alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. Szweras M; Liu D; Partridge EA; Pawling J; Sukhu B; Clokie C; Jahnen-Dechent W; Tenenbaum HC; Swallow CJ; Grynpas MD; Dennis JW J Biol Chem; 2002 May; 277(22):19991-7. PubMed ID: 11901155 [TBL] [Abstract][Full Text] [Related]
13. TGF-β inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling. Sun X; Xie Z; Ma Y; Pan X; Wang J; Chen Z; Shi P J Cell Physiol; 2018 Jan; 233(1):596-606. PubMed ID: 28322449 [TBL] [Abstract][Full Text] [Related]
14. MOTS-c improves osteoporosis by promoting osteogenic differentiation of bone marrow mesenchymal stem cells via TGF-β/Smad pathway. Hu BT; Chen WZ Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7156-7163. PubMed ID: 30468456 [TBL] [Abstract][Full Text] [Related]
15. Tamoxifen attenuates glucocorticoid actions on bone formation in vitro. Sukhu B; Rotenberg B; Binkert C; Kohno H; Zohar R; McCulloch CA; Tenenbaum HC Endocrinology; 1997 Aug; 138(8):3269-75. PubMed ID: 9231777 [TBL] [Abstract][Full Text] [Related]
16. Influence of osteogenic protein-1 (OP-1;BMP-7) and transforming growth factor-beta 1 on bone formation in vitro. Cheifetz S; Li IW; McCulloch CA; Sampath K; Sodek J Connect Tissue Res; 1996; 35(1-4):71-8. PubMed ID: 9084644 [TBL] [Abstract][Full Text] [Related]
17. Interaction of TGF-beta1 and rhBMP-2 on human bone marrow stromal cells cultured in collagen gel matrix. Kim MK; Niyibizi C Yonsei Med J; 2001 Jun; 42(3):338-44. PubMed ID: 11456401 [TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function. Lu L; Yaszemski MJ; Mikos AG J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S82-91. PubMed ID: 11314800 [TBL] [Abstract][Full Text] [Related]
19. Follistatin restricts bone morphogenetic protein (BMP)-2 action on the differentiation of osteoblasts in fetal rat mandibular cells. Abe Y; Abe T; Aida Y; Hara Y; Maeda K J Bone Miner Res; 2004 Aug; 19(8):1302-7. PubMed ID: 15231018 [TBL] [Abstract][Full Text] [Related]
20. Characterization of growth and osteogenic differentiation of rabbit bone marrow stromal cells. Roostaeian J; Carlsen B; Simhaee D; Jarrahy R; Huang W; Ishida K; Rudkin GH; Yamaguchi DT; Miller TA J Surg Res; 2006 Jun; 133(2):76-83. PubMed ID: 16360178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]